Bone-infarct-associated osteosarcomas are rare, aggressive neoplasms with a poor prognosis, and an atraumatic fracture through a bone infarct should prompt evaluation for malignant degeneration.
Answers are grounded in this paper and cite their sources.
Atraumatic fractures through bone infarcts warrant malignancy evaluation; leaves open optimal management strategies for this rare entity.
Benign lesions such as Paget's disease of the bone, enchondroma, osteochondromas, chronic osteomyelitis/infections and bone infarcts may rarely undergo malignant degeneration/transformation into sarcomas. To date, only 14 prior bone infarct-associated osteosarcomas have been described, with just two being primarily osteolytic. We discuss a case of a patient with a humeral bone-infarct, who presented with a presumed benign pathological fracture of the humerus through the bone infarct. Subsequent imaging and biopsy showed that there was a malignant degeneration into a primarily osteolytic osteosarcoma. We review the patient's presentation, radiographic and histologic appearance of the osteosarcoma and discuss the epidemiology, surgical and non-surgical treatment and surveillance of bone-infarct-associated osteosarcomas.
No takes yet. Share an insight, caveat, or question.
McDonald et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: